Marshall Wace LLP Invests $736,000 in Kewaunee Scientific Co. (NASDAQ:KEQU)

Marshall Wace LLP purchased a new position in shares of Kewaunee Scientific Co. (NASDAQ:KEQU - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 11,902 shares of the technology company's stock, valued at approximately $736,000. Marshall Wace LLP owned about 0.41% of Kewaunee Scientific at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. State Street Corp bought a new stake in Kewaunee Scientific during the 3rd quarter valued at $266,000. Barclays PLC bought a new position in shares of Kewaunee Scientific during the third quarter valued at about $121,000. Geode Capital Management LLC boosted its holdings in shares of Kewaunee Scientific by 8.9% during the third quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company's stock worth $792,000 after purchasing an additional 1,941 shares during the period. JPMorgan Chase & Co. lifted its holdings in Kewaunee Scientific by 18,000.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company's stock worth $30,000 after buying an additional 900 shares during the period. Finally, Ritholtz Wealth Management grew its position in shares of Kewaunee Scientific by 15.6% in the 4th quarter. Ritholtz Wealth Management now owns 12,619 shares of the technology company's stock worth $781,000 after buying an additional 1,706 shares during the last quarter. Hedge funds and other institutional investors own 32.69% of the company's stock.

Insider Activity

In related news, CEO Thomas David Hull III sold 3,000 shares of the firm's stock in a transaction that occurred on Monday, March 24th. The shares were sold at an average price of $45.63, for a total transaction of $136,890.00. Following the completion of the sale, the chief executive officer now owns 37,916 shares of the company's stock, valued at $1,730,107.08. This trade represents a 7.33 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Keith M. Gehl bought 1,000 shares of the business's stock in a transaction on Friday, April 4th. The stock was bought at an average cost of $35.00 per share, with a total value of $35,000.00. Following the transaction, the director now owns 18,500 shares in the company, valued at $647,500. This trade represents a 5.71 % increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders sold 11,057 shares of company stock worth $440,326. Insiders own 14.20% of the company's stock.

Kewaunee Scientific Stock Up 4.3 %

Shares of KEQU traded up $1.33 on Wednesday, reaching $32.43. The stock had a trading volume of 11,421 shares, compared to its average volume of 24,507. The firm has a market capitalization of $92.59 million, a price-to-earnings ratio of 5.14 and a beta of 0.47. The company has a 50-day simple moving average of $39.50 and a 200-day simple moving average of $47.29. Kewaunee Scientific Co. has a 12-month low of $30.33 and a 12-month high of $71.33. The company has a debt-to-equity ratio of 0.45, a quick ratio of 2.13 and a current ratio of 2.64.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last announced its earnings results on Wednesday, March 12th. The technology company reported $1.09 EPS for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%. The firm had revenue of $67.17 million for the quarter.

Analysts Set New Price Targets

Separately, StockNews.com cut shares of Kewaunee Scientific from a "buy" rating to a "hold" rating in a research report on Friday, March 14th.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.